Cartesian Therapeutics (RNAC)
Develops outpatient mRNA CAR-T candidates for autoimmune diseases, led by Descartes-08.
$7.64
vs last close−0.44 (−5.45%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
estimated · in 43 days
EPS estimate
−$1.02
Revenue estimate
$180.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26Apr '26Aug '26Nov '26
Reported−$0.59−$0.68$0.50−$1.38−$1.38−$1.46$0.46Pending
Estimate−$0.78−$0.61−$0.76−$0.81−$0.82−$0.84−$0.88−$1.02
Surprise+24.4%−11.5%+165.8%−70.4%−68.3%−73.8%+152.4%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26Apr '26Aug '26Nov '26
Reported$759.0K$1.1M$298.0K$452.0K$947.0K$78.0K$164.0KPending
Estimate$1.0M$916.7K$928.6K$266.3K$150.3K$219.8K$179.7K$180.0K
Surprise−24.1%+20.0%−67.9%+69.7%+529.9%−64.5%−8.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2030 | −$0.46 | — | — |
| Sep 2030 | −$0.80 | — | — |
| Jun 2030 | −$0.92 | — | — |
| Mar 2030 | −$0.74 | — | — |
| Dec 2029 | −$0.77 | — | — |
| Sep 2029 | −$1.01 | — | — |
| Jun 2029 | −$1.08 | — | — |
| Mar 2029 | −$0.81 | — | — |
| Dec 2028 | −$0.79 | — | — |
| Sep 2028 | −$1.05 | — | — |
| Jun 2028 | −$1.14 | — | — |
| Mar 2028 | −$0.81 | — | — |
| Dec 2027 | −$0.95 | — | — |
| Sep 2027 | −$1.01 | — | — |
| Jun 2027 | −$1.01 | — | — |
| Mar 2027 | −$0.97 | — | — |
| Dec 2026 | −$1.09 | — | — |
| Nov 2026 | −$1.02 | — | — |
| Aug 2026 | −$0.88 | $0.46 | +152.4% |
| Apr 2026 | −$0.84 | −$1.46 | −73.8% |
| Mar 2026 | −$0.82 | −$1.38 | −68.3% |
| Nov 2025 | −$0.81 | −$1.38 | −70.4% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2030 | −$0.46 | — | — | $23.2M | — | — | — |
| Sep 2030 | −$0.80 | — | — | $15.2M | — | — | — |
| Jun 2030 | −$0.92 | — | — | $8.6M | — | — | — |
| Mar 2030 | −$0.74 | — | — | $3.3M | — | — | — |
| Dec 2029 | −$0.77 | — | — | $78.0K | — | — | — |
| Sep 2029 | −$1.01 | — | — | $78.0K | — | — | — |
| Jun 2029 | −$1.08 | — | — | $78.0K | — | — | — |
| Mar 2029 | −$0.81 | — | — | $78.0K | — | — | — |
| Dec 2028 | −$0.79 | — | — | $78.0K | — | — | — |
| Sep 2028 | −$1.05 | — | — | $78.0K | — | — | — |
| Jun 2028 | −$1.14 | — | — | $78.0K | — | — | — |
| Mar 2028 | −$0.81 | — | — | $78.0K | — | — | — |
| Dec 2027 | −$0.95 | — | — | $82.0K | — | — | — |
| Sep 2027 | −$1.01 | — | — | $75.0K | — | — | — |
| Jun 2027 | −$1.01 | — | — | $75.0K | — | — | — |
| Mar 2027 | −$0.97 | — | — | $82.0K | — | — | — |
| Dec 2026 | −$1.09 | — | — | $340.0K | — | — | — |
| Nov 5, 2026 | −$1.02 | — | — | $180.0K | — | — | — |
| Aug 6, 2026 | −$0.88 | $0.46 | +152.4% | $179.7K | $164.0K | −8.7% | +4.9% |
| Apr 30, 2026 | −$0.84 | −$1.46 | −73.8% | $219.8K | $78.0K | −64.5% | −3.9% |
| Mar 9, 2026 | −$0.82 | −$1.38 | −68.3% | $150.3K | $947.0K | +529.9% | +31.7% |
| Nov 6, 2025 | −$0.81 | −$1.38 | −70.4% | $266.3K | $452.0K | +69.7% | −1.6% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 7, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 17, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 2, 2023 | |||||||
| Dec 30, 2022 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Dec 30, 2021 | |||||||
| Sep 29, 2021 | |||||||
| Jun 29, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 30, 2015 | |||||||
| Sep 30, 2015 |